Pulmonary embolism (PE)

Diagnostic and therapeutic approach

  1. Diagnosis
  2. Scores
  3. Treatment
  4. Pharmaceuticals
  5. ESC recommandations

Treatment

  1. Low risk
  2. Intermediate to high risk

Low risk

Anticoagulation

AVK (Sintrom ou Marcoumar) following treatment initiation with héparine non fractionnée or Fondaparinus (Arixtra).

or

  1. Rivaroxaban (Xarelto) 20 mg/day.
  2. Dabigatran (Pradaxa) 2 x 150 mg/day.
  3. Edoxaban (Lixiana) 30 ou 60 mg/day.